South Carolina-based web3 healthcare technology firm Rymedi has been expanding its patient and population data management offering to US and global customers with a three-tier L1 (Formerly known as Subnets) architecture powered by Avalanche.
Rymedi initially utilized a public blockchain, as their significant focus then was on bolstering transparency and removing accessibility barriers for users. Over the years, Rymedi continued to grow, and it is now one of the fastest-growing healthcare technology startups in South Carolina.
In August 2023, Rymedi launched an updated version of its platform on three distinct Avalanche L1s (Formerly known as Subnets) – Identity Subnet, Transaction Subnet, and Compliance Subnet. These highly scalable, permissioned, and compliance-oriented subnets provide Rymedi the ability to serve over a million patients and millions of daily transactions without hassle.
As one of the top healthcare tech firms, Rymedi empowers life science companies to improve human health. Rymedi caters to the data needs of clinical diagnostic and toxicology testing device companies, clinical trials and patient registries, and clinical research and commercial.
With the three-tier L1 (Formerly known as Subnets) architecture, including Identity, Transaction, and Compliance, Rymedi is able to:
● Segregate Protected health information (PHI), personally identifiable information (PII), and vital patient-centric data for streamlined record keeping.
● Ensure smooth operation of multi-jurisdictional regulatory submissions for virtual clinical trials globally.
● Partner with major organizations like Clemson University, the Precision Medicine Institute, Precision Genetics, and Biospy.
As a highly mature appchain ecosystem, Avalanche extends Rymedi’s capabilities to achieve around 750k TPS. Further, it allows for designing the network with specific compliance in mind and granting Rymedi complete control of on-chain data. It is up to Rymedi to define who can participate in their L1s (Formerly known as Subnets), who can be validators, or who can access the data. Avalanche L1s (Formerly known as Subnets) support growth on the Rymedi platform, enabling it to scale globally and serve its expanding list of users while fully complying with industry standards like ISO, WCAG 2.1AA, HIPAA, FDA, GAMP, and ADA.
To manage all three distinct L1s, Rymedi leverages Zeeve’s appchain services
From deployment to management and scaling– Zeeve caters to everything with its enterprise-grade infrastructure designed for network performance, reliability, and scalability. Rymedi subnets also benefit from Zeeve’s enterprise SLA– 24×7 support team, 24×7 infrastructure monitoring, and guaranteed 99.9% uptime.
Additionally, Zeeve uses its Avalanche L1 management dashboard integrated with features like summarized L1 (Formerly known as Subnets) viewing, configurations, wallet & validator management, accounts & access control, nodes, and infrastructure monitoring. With the Zeeve L1 (Formerly known as Subnets) dashboard, Rymedi can easily onboard validators and allow them to run nodes without any friction, cutting down the hassle & operational/hosting costs while at the same time providing them security and compliance through Zeeve’s ISO, SOC 2 Type II and GDPR Compliance.
While the global healthcare system undergoes a major paradigm shift, Rymedi remains at an inflection point. The firm’s constant effort in innovating cutting-edge data solutions is poised to expand its growth beyond the top-tier countries. Rymedi’s ability to scale dynamically and meet the changing compliance standards is a testament to its suitability in the long run.
